Introduction
'vasculogenic mimicry' [9] , has been extensively described in inflammatory breast cancer [10] . In BioScience, Venviers, Belgium) , supplemented with 10 ng/ml basic fibroblast growth factor (bFGF), 20 ng/ml epidermal growth factor (EGF), 5 g/ml insulin and 0.4% bovine serum albumin (all from Sigma), as described in [6] .
Material and methods

Isolation and in vitro expansion of progenitor cells from breast tumour specimens
Tumour specimens were obtained from a consenting patient according to the Ethics Commitee of the S. Giovanni Battista Hospital of Torino, Italy. The histologic assessment showed a lobular-infiltrating carcinoma of the pleomorphic type expressing oestrogen receptor in about 60% of cells. Tumour specimen was finely minced with scissors and then digested by incubation for 1 h at 37ЊC in DMEM containing collagenase II (Sigma Chemical Company, St. Louis, MO, USA). After washings in medium plus 10% FCS (GIBCO, Grand Island, NY, USA), the cell suspension was forced through a graded series of meshes to separate the cell components from stroma and aggregates. After filtration through a 40-m pore filter (Becton Dickinson, San Jose, CA, USA), single cells were plated at 1000 cells/ml in serum-free DMEM-F12 (Cambrex
After 7 days, the appearance of non-adherent spherical clusters of cells, i.e. mammospheres, was observed. Mammospheres were then collected on the bottom of a conical tube by spontaneous precipitation (20 min. at room temperature), in order to remove non-living cells. Subsequently, after 2-3 days, mammospheres were collected by gentle centrifugation (800 rpm) and disaggregated through enzymatic and mechanical dissociation using trypsin and pipetting, respectively. Recovered cells were expanded at 1000 cells/ml in the serum-free medium described above and the process was repeated every 7 days.
Clonal sphere formation assay
Primary mammospheres were dissociated as described above and 100 cells were plated in a 96-well culture plate to obtain a single cell/well in 200 l of growth medium; 25 
In vitro cell differentiation
Combined fluorescence in situ hybridization (FISH) and immunofluorescence analysis
A combined immunofluorescence and FISH staining was performed to detect CD31 expression on human chromosome 17 positive cells [13] . 
Electron microscopy
Transmission electron microscopy was performed on Karnowsky's fixed, osmium tetraoxide post-fixed tissues, embedded in epoxy resin according to standard procedures [15] . Ultra-thin sections were stained with uranyl acetate and lead citrate and were examined with a Jeol JEM 1010 electron microscope.
Results
Isolation and characterization of breast cancer stem cells
Breast cancer stem cells were generated using the protocol described by Ponti et al. [6] Clonal, non-adherent secondary mammospheres formed, which in turn gave rise to tertiary mammosphere clones (Fig. 1B) [4] [5] [6] (Fig. 1C and D) . Moreover, the cells expressed the VEGF receptor 1 (Fig. 1C) . This phenotype was maintained in all clones.
In vitro epithelial and endothelial differentiation of mammosphere-derived CD44 (Fig. 2B) . This ability was not shared by undifferentiated breast cancer progenitors (Fig. 2B) (Fig. 3) .
or by cells differentiated into an epithelial phenotype (not shown). Moreover, the percentage of differentiation into epithelial and endothelial cells did not significantly vary from primary to single cell-derived secondary and tertiary mammospheres
In Fig. 7A and B) . At this time, only few tumour clusters were seen. After 3 weeks, the epithelial component expanded, generating tumours (Fig. 7C) , expressing CK, 
Fig. 2 Endothelial differentiation of mammosphere clones cultured in endothelial differentiating medium containing VEGF. (A) Representative micrographs showing the expression of endothelial markers after 2-week culture by immunofluorescence staining of vascular endothelial (VE)-cadherin and vWF, and representative FACS analysis (KDR, CD105, CD31, CD146, VEGF receptor 3 (VEGFR3): black area; the white area is the isotypic control) showing the endothelial differentiation. CK18 was negative. (B) Representative micrographs showing the formation of capillary-like structures on
Fig. 4 Morphological appearance of tumours derived from mammospheres. Representative micrographs showing the morphological appearance of a tumour originated from 102 cells from mammospheres (A), resembling the original lobular breast carcinoma (B).
Original magnification: ϫ100. 
Tumours were generated in SCID mice by subcutaneous injection of cells derived from CD24
vimentin and EMA (not shown), thus resembling the tumour originated by mammospheres. The ability of endothelial differentiated clones to generate epithelial tumours in vivo may suggest that in the endothelial differentiated breast cancer stem cells a non-differentiated population is maintained and it is able to differentiate into tumour epithelial cells in vivo.
Discussion
In the present study, we demonstrate that stem/progenitor cells of breast carcinomas cultured as mammospheres could differentiate not only in epithelial cells but also into endothelial cells both in vitro and in vivo.
A tumour-initiating population able to sustain and maintain the tumour has been identified in several organs [1] . The ability to growth in suspension, as floating spheres has been described as a culture system that allows the propagation of normal and tumour mammary stem cells in an undifferentiated state [16] .
In These results show the self-renewal and the tumour-initiating ability of this cell population comparable to that described by Ponti et al. [6] . [19] . Other studies supported the idea that melanoma cells may acquire functional behaviours that are similar to those of endothelial cells [20] . Aggressive melanoma cells that form blood-carrying channels in tumours also exhibited capillary-like structure formation and co-expressed epithelial and some endothelial-like markers [9, 21, 22] .
In [12, 23] , are cytogenetically abnormal [24] and express tumour suppressor genes and oncogenes [23, 25] . In addition, in the case of tumours of hematopoietic origin, endothelial cells were shown to share the tumour-specific genetic alteration, such as chromosomal translocations in B-cell lymphomas, the BCR/ABL fusion gene in leukaemias and the myeloma-specific 13q14 chromosomal deletion [26] [27] [28] . These data may suggest the hypothesis that a common progenitor targeted by neoplastic transformation can differentiate in tumour cells or in endothelial cells sharing the same genetic abnormalities [27] . Regarding [30, 31] , including the mammary cell line MCF7 [6, 32] 
